Work

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL

Year: 2025

Type: article

Abstract: study.

Source: Blood Advances

DOI: 10.1182/bloodadvances.2025017770

Authors: Malte Roerden, Luca Hensen, Britta Besemer, Friederike Schwartz, Kristina Reuss, Alisha Weiss-Haug, Lennart Harland, Franziska Ginsberg, Christoph Faul, Wolfgang Bethge, Claudia Lengerke

Institutions: Universitätsklinikum Tübingen, University of Tübingen, German Cancer Research Center, Deutsches Konsortium für Translationale Krebsforschung

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,800

Funder: Deutsche Forschungsgemeinschaft

Awards: 3Laser Durchflusszytometer, Clinician Scientist Programm Medizinische Innovation durch Interdisziplinarität (MINTCS)

OpenAlex ID: W4414642467

FWCI:

Cites: 16

Cited by:

Related to: